Vaccine Effectiveness Against SARS-CoV-2 Infection and Severe Outcomes in the Maintenance Dialysis Population in Ontario, Canada

COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider

(2021) Caroline M. Hsu et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

COVID-19 in patients undergoing long-term dialysis in Ontario

(2021) Leena Taji et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Short-term antibody response afer 1 dose of BNT162b2 vaccine in patients receiving hemodialysis

(2021) Rémi Goupil et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

(2021) Ayelet Grupper et al.   Clinical Journal of the American Society of Nephrology

Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared to healthy controls

(2021) Benedikt Simon et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

COVID-19 Vaccination Imperatives in People on Maintenance Dialysis

(2021) Peter Blake et al.   Clinical Journal of the American Society of Nephrology

Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications

(2021) Nabeel Khan et al.   GASTROENTEROLOGY

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis

(2021) Shuchi Anand et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients

(2021) Philippe Attias et al.   KIDNEY INTERNATIONAL

Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients

(2021) Noa Berar Yanay et al.   KIDNEY INTERNATIONAL

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study

(2021) Madhumita Shrotri et al.   LANCET INFECTIOUS DISEASES

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

(2021) Mark G. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

(2021) Hannah Chung et al.   BMJ-British Medical Journal

Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis

(2021) Eva Schrezenmeier et al.   Frontiers in Immunology

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis

(2021) Kevin Yau et al.   JAMA Network Open

Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients

(2021) José Jesús Broseta et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Real-World Effectiveness and Immunogenicity of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Patients on Hemodialysis

(2021) Scott Sibbel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

(2021) Sara Y Tartof et al.   LANCET

COVID-19 Outbreak in an Urban Hemodialysis Unit

(2020) Kevin Yau et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.

(2020) Kitty J. Jager et al.   KIDNEY INTERNATIONAL

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients.

(2020) Couchoud Cécile et al.   KIDNEY INTERNATIONAL

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of the influenza vaccine on pediatric kidney transplant outcomes

(2019) Megan Camerino et al.   PEDIATRIC TRANSPLANTATION

A review of the use of time‐varying covariates in the Fine‐Gray subdistribution hazard competing risk regression model

(2019) Peter C. Austin et al.   STATISTICS IN MEDICINE

Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes

(2018) Inga Poguntke et al.   BMC Medical Research Methodology

Multiple time scales in modeling the incidence of infections acquired in intensive care units

(2016) Martin Wolkewitz et al.   BMC Medical Research Methodology

Competing Risk Regression Models for Epidemiologic Data

(2009) B. Lau et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

(2009) Peter C. Austin   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION

Time-dependent covariates in the proportional subdistribution hazards model for competing risks

(2008) J. Beyersmann et al.   BIOSTATISTICS